Hospital Provincial de Rosario, Leandro N Alen 1450, Rosario, Santa Fe, Argentina.
Servicio Enfermedades Autoinmunes, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.
Clin Rheumatol. 2018 Sep;37(9):2323-2330. doi: 10.1007/s10067-018-4103-5. Epub 2018 Apr 19.
To describe the baseline and follow up epidemiological/clinical characteristics of rheumatoid arthritis (RA) in a community-based cohort of the qom population. RA (ACR criteria) patients identified (n = 40) or not (n = 25) in the previous study were included. Baseline and follow-up visits (3, 6, and 12 months) were performed. Treatment adherence and modification, disability (Health Assessment Questionnaire Disability Index-HAQ-DI), and Disease Activity [DAS-28 (ESR)] were ascertained. At 12 months, complete and incomplete lost to follow-up patients were identified. The estimated RA prevalence was 3%. The patients' mean (SD) disease duration was 110.5 (17.9) and their median delay in diagnosis 30.4 (IQR 52.8) months; mean (SD) age and years of formal education were 39.8 (1.6) and 5.3 (SD 0.3); 58 (89.2%) were female, and 89.2% were seropositive. At baseline, their mean DAS-28 (ESR) was 4.8 (SD 0.9) with 67.7% having high disease activity and 32.3% moderate; 76.9% reported HAQ-DI ≥ 0.8. At 12 months, three patients have died; 13 (20.9%) were "completely" and 19 (30.6%) "incompletely" lost to follow-up. There were favorable changes over time for disease activity (p ˂ 0.001), HAQ-DI (p ˂ 0.001), and treatment modifications (p ˂ 0.001) but no changes in treatment adherence (p = 0.260). The main cause of lost to follow-up was migration. This population has one of the highest RA prevalence rate reported. Patients had an aggressive and disabling disease, with poor adherence to treatment. Improvements of clinical parameters over time were observed.
描述基于社区的库姆人群类风湿关节炎(RA)的基线和随访流行病学/临床特征。纳入了在前一项研究中确定的 RA(ACR 标准)患者(n=40)或未确定的患者(n=25)。进行了基线和随访访视(3、6 和 12 个月)。确定了治疗依从性和调整、残疾(健康评估问卷残疾指数-HAQ-DI)和疾病活动[DAS28(ESR)]。在 12 个月时,确定了完全和不完全失访的患者。估计 RA 的患病率为 3%。患者的平均(SD)疾病持续时间为 110.5(17.9),中位诊断延迟时间为 30.4(IQR 52.8)个月;平均(SD)年龄和正规教育年限分别为 39.8(1.6)和 5.3(SD 0.3);58 名(89.2%)为女性,89.2%为血清阳性。基线时,他们的平均 DAS28(ESR)为 4.8(SD 0.9),67.7%的患者疾病活动度高,32.3%为中度;76.9%报告 HAQ-DI≥0.8。在 12 个月时,有 3 名患者死亡;13 名(20.9%)完全失访,19 名(30.6%)不完全失访。疾病活动度(p<0.001)、HAQ-DI(p<0.001)和治疗调整(p<0.001)随时间的变化是有利的,但治疗依从性没有变化(p=0.260)。失访的主要原因是迁移。该人群的 RA 患病率是报告的最高之一。患者患有侵袭性和致残性疾病,治疗依从性差。随着时间的推移,观察到临床参数的改善。